The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial

The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial

<b>Background</b>: Influenza is a serious contagious disease caused by influenza virus. It is particularly dangerous for children, potentially leading to severe and even fatal complications. The aim of this study was to evaluate the safety and immunogenicity of two candidate quadrivalent...

Full description

Saved in:
Bibliographic Details
Main Authors: Lili Huang, Guangfu Li, Yuhui Zhang, Xue Zhao, Kai Wang, Chunyu Jia, Wei Zhang, Jiebing Tan, Xiaofen Chen, Qin Li, Hongyan Jiang, Rui An, Wenna Leng, Yongli Yang, Youcai An, Yanxia Wang, Yaodong Zhang
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
influenza vaccine
safety
immunogenicity
subunit
clinical trial
children
Online Access:https://www.mdpi.com/2076-393X/13/5/467
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items